Langhans Bettina, Ahrendt Manuela, Nattermann Jacob, Sauerbruch Tilman, Spengler Ulrich
Department of Internal Medicine I, University of Bonn, Germany.
J Immunol Methods. 2005 Nov 30;306(1-2):161-8. doi: 10.1016/j.jim.2005.08.010. Epub 2005 Sep 13.
Cell-mediated cytotoxicity is a major effector pathway of the immune system. Thus far, radioactive assays have been widely used, but have significant disadvantages. Meanwhile, flow cytometric assays have been established but have not all been assessed simultaneously relative to the radioactive assays. Here, we have evaluated flow cytometric enumeration of surviving target cells, annexin-V binding and detection of activated caspase-3 and caspase-6 in direct comparison to the 51chromium (51Cr) release assay, and the JAM test. For assay evaluation NKL effector cells Fas-resistant K562 and Fas-sensitive Jurkat target cells were studied. Percent specific lysis measured for each E:T ratio was fitted to a sigmoid dose response curve. Both the flow cytometric and radioactive cytotoxicity assays showed equivalent background lysis (1-13%) but differed considerably with respect to maximum cytotoxicity (11-82% in K562 and 49-75% in Jurkat cells). Half maximum lysis ranged from 4:1 to 28:1 E:T ratios in K562 cells and from 1:3 to 24:1 in Jurkat cells, respectively. Flow cytometric enumeration of surviving target cells was the only assay which permitted detection of cytotoxicity at considerable lower E:T ratios (in K562 cells 1:4 to 2:1 and in Jurkat cells 1:4 to 1:1) than the conventional assays. Prolonged incubation over 24 h did not improve the sensitivity for flow cytometric enumeration of surviving target cells or the JAM test. The observed differences in the lysis of target cells are likely to reflect different sensitivity of cell death-associated changes which are measured by each assay. Thus, the particular choice of a cytotoxicity assay must be carefully adapted to the experimental situation under study.
细胞介导的细胞毒性是免疫系统的主要效应途径。到目前为止,放射性检测方法已被广泛使用,但存在显著缺点。同时,流式细胞术检测方法已经建立,但尚未全部与放射性检测方法同时进行评估。在此,我们通过与51铬(51Cr)释放试验和JAM试验直接比较,评估了存活靶细胞的流式细胞术计数、膜联蛋白-V结合以及活化的半胱天冬酶-3和半胱天冬酶-6的检测。为了评估检测方法,研究了NKL效应细胞(对Fas耐药的K562细胞和对Fas敏感的Jurkat靶细胞)。针对每个效靶比测量的特异性裂解百分比拟合为S形剂量反应曲线。流式细胞术和放射性细胞毒性检测均显示出相当的背景裂解率(1%-13%),但在最大细胞毒性方面有很大差异(K562细胞中为11%-82%,Jurkat细胞中为49%-75%)。在K562细胞中,半数最大裂解的效靶比范围为4:1至28:1,在Jurkat细胞中为1:3至24:1。存活靶细胞的流式细胞术计数是唯一一种能够在比传统检测方法低得多的效靶比下检测细胞毒性的方法(在K562细胞中为1:4至2:1,在Jurkat细胞中为1:4至1:1)。超过24小时的延长孵育并未提高存活靶细胞的流式细胞术计数或JAM试验的灵敏度。观察到的靶细胞裂解差异可能反映了每种检测方法所测量的细胞死亡相关变化的不同敏感性。因此,细胞毒性检测方法的具体选择必须仔细适应所研究的实验情况。